1
TITLE: Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results  Full Text
AUTHORS: Thomas Zilli; Sandra Jorcano; Samuel Bral; Carmen Rubio; Anna M E Bruynzeel; Angelo Oliveira; Ufuk Abacioglu; Heikki Minn; Zvi Symon; Raymond Miralbell;
PUBLISHED: 2020, SOURCE: CANCER MEDICINE, VOLUME: 9, ISSUE: 9
INDEXED IN: Scopus WOS
2
TITLE: Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial
AUTHORS: Maud Jaccard; Thomas Zilli; Angele Dubouloz; Lluis Escude; Sandra Jorcano; Nadine Linthout; Samuel Brat; Wilko Verbakel; Anna Bruynzeel; Mikko Bjorkqvist; Heikki Minn; Lev Tsvang; Zvi Symon; Joana Lencart; Angelo Oliveira; Zeynep Ozen; Ufuk Abacioglu; Juan Maria Perez Moreno; Carmen Rubio; Michel Rouzaud; Raymond Miralbell; ...More
PUBLISHED: 2020, SOURCE: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, VOLUME: 108, ISSUE: 4
INDEXED IN: Scopus WOS
3
TITLE: Urethra-sparing SBRT for prostate cancer: dosimetric optimization with VMAT vs. IMRT and the learning curve effect  Full Text
AUTHORS: Zilli, T.; Symon, Z.; Bral, S.; Bruynzeel, A.; Minn, H.; Jorcano, S.; Oliveira, A.; Abacioglu, U.; Rubio, C.; Miralbell, R.;
PUBLISHED: 2016, SOURCE: RADIOTHERAPY AND ONCOLOGY, VOLUME: 118
INDEXED IN: WOS
4
TITLE: Urethra-Sparing Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Dosimetric Results From a Prospective Multicenter Randomized Phase 2 Trial
AUTHORS: Zilli, T; Tsvang, L; Symon, Z; Abacioglu, U; Bruynzeel, A; Rouzaud, M; Dubouloz, A; Pampallona, S; Oliveira, A; Minn, H; Ozen, Z; Perez Moreno, J; Sanchez Saugar, ES; Jorcano, S; Escude, L; Miralbell, R;
PUBLISHED: 2014, SOURCE: 56th Annual Meeting of the American-Society-for-Radiation-Oncology in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, VOLUME: 90
INDEXED IN: WOS